Fresenius raises loan facility for APP takeover

FRANKFURT, Sept 30 (Reuters) - German healthcare company Fresenius (FREG_p.DE) said on Tuesday it raised the credit facility to pay for the takeover of APP Pharmaceuticals by $500 million to $2.95 billion due to strong demand from investors.

The company increased a loan with a maturity of 6 years to $1.5 billion, it said. The credit facility also consists in a revolving credit facility of $450 million with a maturity of 5 years and a $1 billion loan which matures in 5 years.

Fresenius announced in July it planned to buy APP for $3.7 billion. (Reporting by Peter Dinkloh; Editing by David Cowell)